Effect of Topical Brimonidine 0.15% on Conjunctival Injection After Strabismus Surgery in Children

Overview

Journal J Ophthalmol

Publisher Wiley

Specialty Ophthalmology

Date 2021 May 31

PMID 34055396

Authors

Dong Hyun Kim

Hee Kyung Yang

Sang Beom Han

Jeong-Min Hwang

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the effects of topical brimonidine 0.15% instillation on conjunctival injection after strabismus surgery in children.

Methods: We retrospectively analyzed 63 Korean children who underwent strabismus surgery for intermittent exotropia. Patients received topical brimonidine 0.15% after surgery for up to 4 weeks. Conjunctival injection was objectively assessed using a software that automatically scored the region of interest from the image of the bulbar conjunctiva. Conjunctival injection scores were compared with those of the control group who were not prescribed topical brimonidine.

Results: The mean scores of conjunctival injection after rectus muscle recession and resection were significantly lower in the brimonidine group than the controls at 4 weeks after surgery ( = 0.008 and 0.046, respectively). There was no significant difference in intraocular pressure between the two groups. No adverse effects, such as dry mouth, fatigue/drowsiness, headache, sedation, hypotension, or bradycardia, were reported.

Conclusions: Administration of topical brimonidine 0.15% after strabismus surgery is efficacious and safe in reducing postoperative conjunctival injection.

References

Levy Y, Zadok D . Systemic side effects of ophthalmic drops. Clin Pediatr (Phila). 2004; 43(1):99-101. DOI: 10.1177/000992280404300114. View

Yoo Y, Yang H, Hwang J . Efficacy and Safety of Loteprednol 0.5% and Fluorometholone 0.1% After Strabismus Surgery in Children. J Ocul Pharmacol Ther. 2018; 34(6):468-476. DOI: 10.1089/jop.2017.0145. View

Bradbury J, Taylor R . Severe complications of strabismus surgery. J AAPOS. 2013; 17(1):59-63. DOI: 10.1016/j.jaapos.2012.10.016. View

Tappeiner C, Sarra G, Abegg M . Abuse of vasoconstrictive eyedrops mimicking an ocular pemphigoid. Eur J Ophthalmol. 2009; 19(1):129-32. DOI: 10.1177/112067210901900119. View

Bowman R, Cope J, Nischal K . Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children. Eye (Lond). 2004; 18(1):24-6. DOI: 10.1038/sj.eye.6700520. View

Han S, Jeon H, Kim M, Lee S, Yang H, Hwang J . Risk Factors for Recurrence After Pterygium Surgery: An Image Analysis Study. Cornea. 2016; 35(8):1097-103. DOI: 10.1097/ICO.0000000000000853. View

ARMALY M . EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE. Arch Ophthalmol. 1963; 70:482-91. DOI: 10.1001/archopht.1963.00960050484010. View

Desco M, Navea A, Ferrer E, Menezo J . Effect of prophylactic brimonidine on bleeding complications after cataract surgery. Eur J Ophthalmol. 2005; 15(2):228-32. DOI: 10.1177/112067210501500209. View

Kwok A, Lam D, Ng J, Fan D, Chew S, Tso M . Ocular-hypertensive response to topical steroids in children. Ophthalmology. 1997; 104(12):2112-6. DOI: 10.1016/s0161-6420(97)30052-9. View

10.

Han S, Jeon H, Kim M, Lee S, Yang H, Hwang J . Quantification of Astigmatism Induced by Pterygium Using Automated Image Analysis. Cornea. 2015; 35(3):370-6. DOI: 10.1097/ICO.0000000000000728. View

11.

Adkins J, Balfour J . Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs Aging. 1998; 12(3):225-41. DOI: 10.2165/00002512-199812030-00005. View

12.

Dahlmann-Noor A, Cosgrave E, Lowe S, Bailly M, Vivian A . Brimonidine and apraclonidine as vasoconstrictors in adjustable strabismus surgery. J AAPOS. 2009; 13(2):123-6. DOI: 10.1016/j.jaapos.2008.12.001. View

13.

Park I, Chun Y, Kim K, Yang H, Hwang J . New clinical grading scales and objective measurement for conjunctival injection. Invest Ophthalmol Vis Sci. 2013; 54(8):5249-57. DOI: 10.1167/iovs.12-10678. View

14.

Escardo-Paton J, Harrad R . Duration of conjunctival redness following adult strabismus surgery. J AAPOS. 2009; 13(6):583-6. DOI: 10.1016/j.jaapos.2009.09.013. View

15.

Daubert G . Is brimonidine ophthalmic a safe therapy for infants?. J Clin Pharm Ther. 2006; 31(3):289-92. DOI: 10.1111/j.1365-2710.2006.00734.x. View

16.

Norden R . Effect of prophylactic brimonidine on bleeding complications and flap adherence after laser in situ keratomileusis. J Refract Surg. 2002; 18(4):468-71. DOI: 10.3928/1081-597X-20020701-10. View

17.

Graham R, Perez D, Hwa J, Piascik M . alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996; 78(5):737-49. DOI: 10.1161/01.res.78.5.737. View

18.

Wan M, Hunter D . Complications of strabismus surgery: incidence and risk factors. Semin Ophthalmol. 2014; 29(5-6):421-8. DOI: 10.3109/08820538.2014.959190. View

19.

Soparkar C, Wilhelmus K, Koch D, Wallace G, Jones D . Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Arch Ophthalmol. 1997; 115(1):34-8. DOI: 10.1001/archopht.1997.01100150036004. View

20.

Ohji M, Kinoshita S, Ohmi E, Kuwayama Y . Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol. 1991; 112(4):450-4. DOI: 10.1016/s0002-9394(14)76256-7. View